RxDoctor Payments Data

Laura Garrett

Family · Mt Sterling, ILNPI 1104337369

Payments from drug & device makers

$1,511in general payments, 2019–2025

Across 81 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$293
  • Novo Nordisk$179
  • Lilly USA, LLC$152
  • AstraZeneca$129
  • AbbVie$105
  • Otsuka America Pharmaceutical, Inc.$91
  • plus $562 from 14 others

What the payments were for

  • Food & beverage$1,511100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,511 in reported general payments places this provider in the 80th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$877
Medicare patients
27
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide29$39,273
JardianceEmpagliflozin26$20,816
XareltoRivaroxaban22$19,519
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog26$18,513
EliquisApixaban21$16,561
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$10,230
Incruse ElliptaUmeclidinium Bromide17$9,364
ArexvyRsvpref3 Antigen/As01e/Pf17$5,092
ShingrixVaricella-Zoster Ge/As01b/Pf18$3,798
Potassium Chloride49$2,089
Albuterol Sulfate HfaAlbuterol Sulfate57$1,376
Gabapentin74$876
Omeprazole90$774
Atorvastatin Calcium150$666
Lisinopril92$589

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$152$39,27329 claims
Boehringer IngelheimJardiance$18$20,81626 claims
Johnson & JohnsonXarelto$65$19,51922 claims
PfizerEliquis$293$16,56121 claims
AstraZenecaBreztri Aerosphere$129$10,23016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,941 family providers in Illinois.

Other family in Mt Sterling

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →